Friday, August 19, 2022

Biodefense

PharmAthene Reports First Quarter 2016 Financial and Operational Results

ANNAPOLIS, Md., May 9, 2016 - PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the first quarter of 2016. For the three months ended March 31, 2016,...
- Advertisement -

Latest News

IAI Delivers First Sets of F-16 Aerostructures and 200th F-35 Wing to LM

June 14, 2022 - During a ceremony held at Israel Aerospace Industries' (IAI) wing assembly line, IAI delivered Lockheed...
- Advertisement -